Tempus AI announces collaboration with Biontech
- Tempus AI (NASDAQ:TEM) announced a multi-year collaboration with BioNTech SE (NASDAQ:BNTX) which leverages Tempus’ multimodal datasets in support of BioNTech’s next-generation oncology pipeline.
- Under this collaboration, Tempus is providing analytical support and computational biology expertise to BioNTech across its comprehensive research and development oncology pipeline.
- Source: Press Release